Evommune

Evommune is a clinical-stage biotech developing therapies for chronic inflammatory diseases using a proprietary tissue-based discovery platform.
Domain
Healthcare
Status
IPO’d/​Acquired
IPO Date
2025
Stage of Initial Investment
Series C
Initial Investment Year
2024
Evommune Hover Image